Boenisch Sandra 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Jan 9, 2026
Insider Transaction Report
Form 4
Boenisch Sandra
PFO & Treasurer
Transactions
- Award
Stock Option (Right to Buy)
2026-01-06+12,500→ 12,500 totalExercise: $8.58From: 2026-01-06Exp: 2035-03-31→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]On March 31, 2025, the reporting person was granted an option to purchase 50,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which was a second regulatory dialogue for blarcamesine. The performance criteria for this milestone was met, resulting in vesting of the option as to 12,500 shares.